Texas

LATEST FROM BIOSPACE
Alcon will officially step out from under the Novartis umbrella on April 9 as it will trade on the NYSE and the SIX Swiss Exchange.
For years, the biggest employers of science and engineering PhDs has been academic institutions. For example, according to the U.S. National Science Foundation (NSF)’s biennial Survey of Doctoral Recipients, academia employed 11 percent more PhDs than the private sector in 1997.
March is Women’s History Month, with March 8 designated as International Women’s Day. Let’s take a look at 10 pioneers, some still alive, and some who are no longer with us, who are pioneers in the field of biotechnology.
Alcon said the acquisition of PowerVision demonstrates its commitment to bringing advanced technology intraocular lenses to cataract patients across the globe.
FDA
It’s a busy week for the U.S. Food and Drug Administration (FDA) with quite a number of pending drug approvals, several of which were delayed for a variety of reasons. Here’s a look.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know if you’ve updated your resume and components that make it competitive.
With concerns over the costs of prescription drugs taking center stage in American politics during a time when there are shortages of insulin and medical devices like EpiPens, it’s no wonder that the general public is frustrated and is calling on the government to take action of some kind.
Pharma and biotech companies make changes to leadership roles, with new hires at Agios, Notable, Rapamycin, Confo, AVEO and more.
According to a recent BioSpace survey, 70% of life science employers indicated their company anticipates an increase in the number of open positions during 2019. So if you are on the job hunt, keep your eye out for new positions posted throughout the year!
Evaluate recently published the Vantage Pharma, Biotech and Medtech 2018 in review report. The annual report offers insights into the previous year’s activities in biopharma and the medical device industry.
PRESS RELEASES